EP 112: Making the leap: the scientists collaborating to transform genetic targets into next generation treatments, with David Ochoa
Nov 23, 2023•42 min•Ep 112•Transcript available on Metacast Episode description
This week on The Genetics Podcast Patrick is joined by David Ochoa, Platform Coordinator at Open Targets. They discuss how the Open Targets platform is enabling game-changing collaboration between academic research and big pharma. Working with partners including Sanofi, GlaxoSmithKline, Bristol Myers Squibb, Genentech and Pfizer, Open Targets powers collaboration between some of the world’s biggest drug development pioneers and most renowned academic institutions with the goal of accelerating production of effective drug treatments.
